IPO - Femto Technologies Inc.
Form Type: CORRESP
Filing Date: 2025-04-08
Corporate Action: Ipo
Type: New
Accession Number: 000164117225003219
Filing Summary: Femto Technologies Inc. is requesting to accelerate the effective date of their Registration Statement on Form F-1, with the intention for it to be declared effective at 9:00 A.M. (Eastern Time) on April 9, 2025. The company aims to expedite this process and has provided contact details for confirmation of this effectiveness. The request is part of the standard procedure for initiating an IPO process, aimed at allowing the company to begin trading on the stock market under the specified registration.
Additional details:
Registration Statement: Form F-1
File No: 333-285755
Contact Person Name: Louis A. Brilleman
Contact Person Phone: (212) 537-5852
Ceo Name: Yftah Ben Yaackov
Ceo Title: Chief Executive Officer
Form Type: F-1/A
Filing Date: 2025-04-01
Corporate Action: Ipo
Type: Update
Accession Number: 000164117225002139
Filing Summary: On April 1, 2025, Femto Technologies Inc. filed an amendment to its Form F-1 registration statement under the Securities Act of 1933. This filing is in relation to the initial public offering (IPO) of approximately 233,352,911 Common Shares, including shares to be sold by selling shareholders. The offering comprises Common Shares and various pre-funded and series warrants that could potentially lead to significant dilution for current shareholders. As an emerging growth company, Femto is subject to reduced reporting requirements. Recent private placements raised around $17 million and adjusted the terms of existing warrants, indicating active capital management amidst fluctuations in the market. The last reported sale price of Femto's shares was $1.22 on Nasdaq as of March 31, 2025, highlighting the current trading context. The company has undergone strategic changes, including a name change designed to reflect its focus on female wellness technologies. Additionally, significant risks have been identified that stem from operational impacts due to regional conflicts, impacting project timelines and potential cash flows moving forward. Notably, this prospectus emphasizes the high-risk nature of investing in Femto's securities, particularly in light of market volatility and the ongoing geopolitical tensions affecting its operations.
Additional details:
Business Overview: Femto Technologies Inc. develops unique health devices and client relationship management software, focusing on female wellness.
Recent Developments: On February 28, 2025, completed a private placement generating $17 million.
Common Shares Registered: 233,352,911 Common Shares registered for resale under this prospectus.
Last Sale Price: $1.22 per Common Share on Nasdaq as of March 31, 2025.
Emerging Growth Company: Yes
Segments: Femto focuses on health technologies for women, including intimacy products and CRM solutions.
Private Placement Amount: $17 million from institutional investors.
Risk Factors: Investment is subject to high risks due to market volatility and operational safety concerns.
Comments
No comments yet. Be the first to comment!